Skip to main navigation Skip to search Skip to main content

A Phase 2, Randomized, Open-label (with Blinded Plasminogen Activator and Placebo Control Groups) Study to Evaluate the Effects of Different Intra-thrombus Infusion Regimens of Plasmin

Project: Research

Project Details

StatusFinished
Effective start/end date04/21/11 → 08/31/12

Funding

  • Grifols Therapeutics Incorporated: $9,806.36